Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2992)
All Articles published online
|
Feb 15, 2004 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zalewski B. Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features. World J Gastroenterol 2004; 10(4): 583-585 [PMID: 14966921 DOI: 10.3748/wjg.v10.i4.583] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i4/583.htm |
| Number | Citing Articles |
| 1 |
Zahra Amirghofran, Seyed Amir Jalali, Seyed Vahid Hosseini, Mohammad Vasei, Behnam Sabayan, Abbas Ghaderi. Evaluation of CD44 and CD44v6 in Colorectal Carcinoma Patients: Soluble Forms in Relation to Tumor Tissue Expression and Metastasis. Journal of Gastrointestinal Cancer 2008; 39(1-4) doi: 10.1007/s12029-009-9062-2
|
| 2 |
Andrej Veljković, Goran Stanojević, Branko Branković, Dušica Pavlović, Ivana Stojanović, Tatjana Cvetković, Tatjana Jevtović, Dušan Sokolović, Jelena Bašić, Milena Despotović, Branka Đorđević, Gordana Kocić. PARAMETERS OF OXIDATIVE STRESS IN COLON CANCER TISSUE. Acta Medica Medianae 2016; 55(3): 32 doi: 10.5633/amm.2016.0305
|
| 3 |
Poournima Patil, Suresh Killedar, Harinath More, Ganesh Vambhurkar. Development and Characterization of 5-Fluorouracil Solid Lipid Nanoparticles for Treatment of Colorectal Cancer. Journal of Pharmaceutical Innovation 2022; 17(4): 1268 doi: 10.1007/s12247-021-09605-x
|
| 4 |
Olfa Baroudi, Sonia Ben Younes, Amel Mézlini, Yves Jean Bignon, Imen Medimeg, Nancy Uhrhammer, Amel Ben Ammar EL Gaiied, Soufia Chabchoub Ellouz. Status of antioxidant enzyme: glutathione peroxidase and total polyphenol level in plasma of Tunisian patients suffering from colorectal and gastric cancer: interaction with clinical outcome. Medical Oncology 2013; 30(4) doi: 10.1007/s12032-013-0731-4
|
| 5 |
Pina Ziranu, Andrea Pretta, Valentina Aimola, Flaviana Cau, Stefano Mariani, Alessandra Pia D’Agata, Claudia Codipietro, Daiana Rizzo, Veronica Dell’Utri, Giorgia Sanna, Giusy Moledda, Andrea Cadoni, Eleonora Lai, Marco Puzzoni, Valeria Pusceddu, Massimo Castagnola, Mario Scartozzi, Gavino Faa. CD44: A New Prognostic Marker in Colorectal Cancer?. Cancers 2024; 16(8): 1569 doi: 10.3390/cancers16081569
|
| 6 |
Zhonghu Li, Kai Chen, Peng Jiang, Xi Zhang, Xiaowu Li, Zhihua Li. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients. Diagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-79
|
| 7 |
Ranjeeta Thapa, George D. Wilson, Shimon Slavin. The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/2087204
|
| 8 |
Jong-Min Baek, Quanri Jin, Joe Ensor, Delphine R. Boulbes, Francisco J. Esteva. Serum CD44 levels and overall survival in patients with HER2-positive breast cancer. Breast Cancer Research and Treatment 2011; 130(3): 1029 doi: 10.1007/s10549-011-1691-z
|
| 9 |
B. Shivananda Nayak, Sneha Pinto. Protein thiols and thiobarbituric acid reactive substance status in colon cancer patients. Scandinavian Journal of Gastroenterology 2007; 42(7): 848 doi: 10.1080/00365520601137264
|
| 10 |
Livia Raso-Barnett, Balazs Banky, Tamas Barbai, Peter Becsagh, Jozsef Timar, Erzsebet Raso, Andrzej T. Slominski. Demonstration of a Melanoma-Specific CD44 Alternative Splicing Pattern That Remains Qualitatively Stable, but Shows Quantitative Changes during Tumour Progression. PLoS ONE 2013; 8(1): e53883 doi: 10.1371/journal.pone.0053883
|
| 11 |
Pantea Rohani, Farahnaz Noroozinia, Parisa Modarresi, Ata Abbasi. CD44 Standard Isoform; Not a Good Marker for Colon Cancer. International Journal of Cancer Management 2017; 10(9) doi: 10.5812/ijcm.9166
|